TickerFacts.

AEON Biopharma, Inc. (AEON): Cash & Equivalents

Annual figures by period end, from SEC filings.

$3.01M
As of 2025-12-31
$3.43M
As of 2026-06-30
-32.4%
3-year compound annual growth
$31.20M2021-12-31: $497.4K2022-12-31: $9.75M2023-07-21: $31.20M2023-12-31: $5.16M2024-12-31: $13.0K2025-12-31: $3.01M$3.01M
2021-12-31 Cash & Equivalents (USD) 2025-12-31
Period endedCash & EquivalentsChange YoYSource filing
2025-12-31$3.01Mn/m2026-03-30, Balance as of period end
2024-12-31$13.0K-99.7%2026-03-30, Balance as of period end
2023-12-31$5.16Mn/a2025-03-24, Balance as of period end
2023-07-21$31.20Mn/a2025-03-24, Balance as of period end
2022-12-31$9.75Mn/m2024-05-14, Balance as of period end
2021-12-31$497.4Kn/a2022-03-28, Balance as of period end

Cash & Equivalents at similar companies

Companies with the same SEC industry code (Pharmaceutical Preparations), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedCash & EquivalentsChange YoY
AEON Biopharma, Inc. (AEON)2025-12-31$3.01Mn/m
CDT Equity Inc. (CDT)2025-12-31$1.51M+172.4%
60 Degrees Pharmaceuticals, Inc. (SXTP)2025-12-31$1.51M-9.0%
Ernexa Therapeutics Inc. (ERNA)2024-12-31$1.73M-77.2%
Polaryx Therapeutics, Inc. (PLYX)2025-12-31$5.14M+11.3%
Petros Pharmaceuticals, Inc. (PTPI)2025-12-31$5.14M+198.9%
Azitra, Inc. (AZTR)2025-12-31$2.07M-54.6%
Greenwich LifeSciences, Inc. (GLSI)2025-12-31$6.18M+51.0%
GeoVax Labs, Inc. (GOVX)2025-12-31$3.09M-44.0%

Compare AEON, CDT, SXTP, ERNA side by side · Screen every company in Pharmaceutical Preparations ↗